Valuation: Clover Corporation Limited

Market Cap 17Cr 12Cr 11Cr 9.86Cr 8.99Cr 17Cr 1.14TCr 119.31Cr 46Cr 584.27Cr 45Cr 44Cr 1.88TCr P/E 2027 *
12.6x
P/E 2028 * 10.1x
Enterprise Value 16Cr 11Cr 9.67Cr 9.03Cr 8.23Cr 16Cr 1.05TCr 109.27Cr 42Cr 535.08Cr 41Cr 40Cr 1.72TCr EV / Sales 2027 *
1.36x
EV / Sales 2028 * 1.11x
Free-Float
76.93%
Yield 2027 *
2.18%
Yield 2028 * 2.18%
1 day-1.44%
1 week+5.10%
Current month-1.44%
1 month+18.39%
3 months+25.61%
6 months-2.83%
Current year+30.38%
1 week 0.99
Extreme 0.99
1.11
1 month 0.84
Extreme 0.84
1.11
Current year 0.7
Extreme 0.7
1.16
1 year 0.62
Extreme 0.615
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
18/11/25 Sell

Chief Executive Officer

2,55,199 0.1528%
18/11/25 Buy

Chief Executive Officer

5,29,638 0.3171%
06/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%+5.10%+46.10%-1.90% 12Cr
+0.20%-4.05%+1.22%-27.92% 23TCr
+0.74%-4.39%-7.88%-16.15% 7.37TCr
+2.67%-1.70%-19.50%+13.13% 4.17TCr
+1.17%-1.75%+35.78%+6.67% 3.83TCr
+0.56%-4.01%-15.17%-19.94% 3.2TCr
-0.91%+4.28%+22.78%+80.85% 3.19TCr
+0.79%-2.24%-14.86%-12.69% 2.84TCr
-1.20%-7.00%-15.56%-34.04% 2.66TCr
-0.62%-3.65%+11.80%+15.93% 2.61TCr
Average +0.26%-2.43%+4.47%+0.39% 5.3TCr
Weighted average by Cap. +0.45%-3.86%-0.04%-10.85%

Financials

2027 *2028 *
Net sales 11Cr 7.99Cr 7.1Cr 6.63Cr 6.04Cr 11Cr 768.03Cr 80Cr 31Cr 392.63Cr 30Cr 29Cr 1.26TCr 13Cr 9.17Cr 8.15Cr 7.6Cr 6.93Cr 13Cr 881.28Cr 92Cr 36Cr 450.52Cr 34Cr 34Cr 1.45TCr
Net income 1.37Cr 95.22L 84.6L 78.96L 71.97L 1.36Cr 92Cr 9.56Cr 3.7Cr 47Cr 3.57Cr 3.5Cr 150.18Cr 1.7Cr 1.18Cr 1.05Cr 97.98L 89.31L 1.68Cr 113.58Cr 12Cr 4.59Cr 58Cr 4.44Cr 4.34Cr 186.35Cr
Net Debt -1.44Cr -1Cr -88.92L -83L -75.65L -1.43Cr -96Cr -10Cr -3.89Cr -49Cr -3.76Cr -3.68Cr -157.85Cr -2.49Cr -1.73Cr -1.54Cr -1.44Cr -1.31Cr -2.47Cr -166.37Cr -17Cr -6.73Cr -85Cr -6.5Cr -6.36Cr -272.96Cr
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
81
Date Price Change Volume
02/26/02 A$1.030 -1.44% 65,121
01/26/01 A$1.045 0.00% 10,70,949
30/26/30 A$1.045 +3.98% 2,31,304
29/26/29 A$1.005 +0.50% 25,867
28/26/28 A$1.000 -7.41% 2,28,372
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.030AUD
Average target price
1.315AUD
Spread / Average Target
+27.67%

Annual profits - Rate of surprise